Opioid Lawsuit Against Teva Pharma
DOJ accuses drugmaker Teva of illegal kickbacks to inflate prices | Fox Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva stock plummets by double figures on back of U.S. government kickback lawsuit | Ctech
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Setback for Teva as court dismisses Copaxone lawsuit - PMLiVE
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Teva CFO says company did not conspire to fix prices - www.israelhayom.com
Allergan, Teva to pay $54M in San Francisco opioid lawsuit
Teva CEO says company could pay up to $3.6B to put opioid litigation to bed: report | Fierce Pharma
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceuticals will pay $420 million in a federal case
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | KTLA
Teva & Allergan Settle WV Opioid Lawsuit For Over $160 Million | MedTruth - Prescription Drug & Medical Device Safety | Informed Advocacy
Teva drops lawsuit with Amicus over Creates Act dispute
New York Jury Finds Drugmaker Teva Liable for Fueling Opioid Crisis
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Stock: Wait And See On This Stock (NYSE:TEVA) | Seeking Alpha
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
